ArticleBio-protocol2025
RACE-Nano-Seq: Profiling Transcriptome Diversity of a Genomic Locus.
Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The complexity of the human transcriptome poses significant challenges for complete annotation. Traditional RNA-seq, often limited by sensitivity and short read lengths, is frequently inadequate for identifying low-abundant transcripts and resolving complex populations of transcript isoforms. Direct long-read sequencing, while offering full-length information, suffers from throughput limitations, hindering the capture of low-abundance transcripts. To address these challenges, we introduce a targeted RNA enrichment strategy, rapid amplification of cDNA ends coupled with Nanopore sequencing (RACE-Nano-Seq). This method unravels the deep complexity of transcripts containing anchor sequences-specific regions of interest that might be exons of annotated genes, in silico predicted exons, or other sequences. RACE-Nano-Seq is based on inverse PCR with primers targeting these anchor regions to enrich the corresponding transcripts in both 5' and 3' directions. This method can be scaled for high-throughput transcriptome profiling by using multiplexing strategies. Through targeted RNA enrichment and full-length sequencing, RACE-Nano-Seq enables accurate and comprehensive profiling of low-abundance transcripts, often revealing complex transcript profiles at the targeted loci, both annotated and unannotated. Key features • This protocol is highly sensitive and can detect low-abundance transcripts. • This protocol can be performed in a typical molecular biology laboratory. • This protocol allows RACE reactions with single or multiple primers, supporting various research scales. • This protocol enables characterization of complex genomic loci and discovery of novel transcripts, exons, and alternative splicing events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.